Latest papers

Evaluation of an osmotic pump for microdialysis sampling in an awake and untethered rat.

The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers

Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications

The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.

Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation.

Delayed L-DOPA-induced hyperalgesia.

Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.

Simultaneous determination of benserazide and levodopa by capillary electrophoresis-chemiluminescence using an improved interface.

Validation of the L-DOPA test for diagnosis of restless legs syndrome.

L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.

Effect of L-dopa decarboxylase inhibitor benserazide on renal function in streptozotocin-diabetic rats.

Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.

A spectroscopic study on applicability of spectral analysis for simultaneous quantification of l-dopa, benserazide and ascorbic acid in batch and flow systems.

Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.

[Idiopathic Parkinson's disease: practical hints for the treatment].

Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.

DOPA-sensitive dystonia-plus syndrome.

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Cholinopositive effect of dilept (neurotensin peptidomimetic) as the basis of its mnemotropic effect.

3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.